Bridging the gap between tumor-on-chip and clinics: a systematic review of 15 years of studies
Open accessThe DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
Abstract
models by enabling precise control over various parameters. These parameters include the properties of the extracellular matrix, mechanical forces exerted on cells, the physico-chemical environment, cell composition, and the architecture of the tumor microenvironment. Such fine control allows ToC to closely replicate the complex microenvironment and interactions within tumors, facilitating the study of cancer progression and therapeutic responses in a highly representative manner. Importantly, by incorporating patient-derived cells or tumor xenografts, ToC models have demonstrated promising results in terms of clinical validation. We also examined the potential of ToC for pharmaceutical industries in which ToC adoption is expected to occur gradually. Looking ahead, given the high failure rate of clinical trials and the increasing emphasis on the 3Rs principles (replacement, reduction, refinement of animal experimentation), ToC models hold immense potential for cancer research. In the next decade, data generated from ToC models could potentially be employed for discovering new therapeutic targets, contributing to regulatory purposes, refining preclinical drug testing and reducing reliance on animal models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Less than a handful of ovarian cancer-based micro-fluidic chips incorporates immune cells, however, the TME plays an essential role in tumor initiation, development and therapy response (Surendran et al., 2021; Bouquerel et al., 2023).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Bouquerel et al., 2023
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
Remodelling the extracellular matrix in development and disease
Bonnans, C., Chou, J., & Werb, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3904 · Cited by 4,367
Reconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250
Of Mice and Not Men: Differences between Mouse and Human Immunology
Mestas, J., & Hughes, C. C. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2731 · Cited by 3,822
Modeling Development and Disease with Organoids
Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196
Principles of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
Anderson, N. M., & Simon, M. C. (2020) · Current Biology · doi:10.1016/j.cub.2020.06.081 · Cited by 2,718
Combination therapy in combating cancer
Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., & Yeger, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16723 · Cited by 2,543
Clinical development success rates for investigational drugs
Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2786 · Cited by 2,536
Bunney, P. E., Zink, A. N., Holm, A. A., Billington, C. J., & Kotz, C. M. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.03.040 · Cited by 2,104
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901
The tumor microenvironment at a glance
Balkwill, F. R., Capasso, M., & Hagemann, T. (2012) · Journal of Cell Science · doi:10.1242/jcs.116392 · Cited by 1,857
Anand, U., Dey, A., Chandel, A. K. S., Sanyal, R., Mishra, A., Pandey, D. K., De Falco, V., Upadhyay, A., Kandimalla, R., Chaudhary, A., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.02.007 · Cited by 1,834
Why 90% of clinical drug development fails and how to improve it?
Sun, D., Gao, W., Hu, H., & Zhou, S. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.002 · Cited by 1,763
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Costa, A., Kieffer, Y., Scholer-Dahirel, A., Pelon, F., Bourachot, B., Cardon, M., Sirven, P., Magagna, I., Fuhrmann, L., Bernard, C., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.011 · Cited by 1,705
Self-citationSmall molecules in targeted cancer therapy: advances, challenges, and future perspectives
Zhong, L., Li, Y., Xiong, L., Wang, W., Wu, M., Yuan, T., Yang, W., Tian, C., Miao, Z., Wang, T., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00572-w · Cited by 1,696
Human organs-on-chips for disease modelling, drug development and personalized medicine
Ingber, D. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00466-9 · Cited by 1,589
Estimation of clinical trial success rates and related parameters
Wong, C. H., Siah, K. W., & Lo, A. W. (2019) · Biostatistics · doi:10.1093/biostatistics/kxx069 · Cited by 1,585
Three-dimensional in vitro cell culture models in drug discovery and drug repositioning
Langhans, S. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00006 · Cited by 1,522
Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
McKeown, S. R. (2014) · The British Journal of Radiology · doi:10.1259/bjr.20130676 · Cited by 1,050
The hypoxic tumour microenvironment
Petrova, V., Annicchiarico-Petruzzelli, M., Melino, G., & Amelio, I. (2018) · Oncogenesis · doi:10.1038/s41389-017-0011-9 · Cited by 1,019
Synthetic alternatives to Matrigel
Aisenbrey, E. A., & Murphy, W. L. (2020) · Nature Reviews Materials · doi:10.1038/s41578-020-0199-8 · Cited by 1,016
Immune-checkpoint inhibitors: long-term implications of toxicity
Johnson, D. B., Nebhan, C. A., Moslehi, J. J., & Balko, J. M. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00600-w · Cited by 982
Nanomedicine(s) under the Microscope
Duncan, R., & Gaspar, R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 981
Cancer nanomedicine: A review of recent success in drug delivery
Tran, S., DeGiovanni, P., Piel, B., & Rai, P. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0175-0 · Cited by 879
Nia, H. T., Munn, L. L., & Jain, R. K. (2020) · Science · doi:10.1126/science.aaz0868 · Cited by 855
Biology of the Extracellular Matrix: An Overview
Yue, B. (2014) · Journal of Glaucoma · doi:10.1097/ijg.0000000000000108 · Cited by 805
Microenvironmental regulation of therapeutic response in cancer
Klemm, F., & Joyce, J. A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.11.006 · Cited by 771
Burridge, P. W., Li, Y. F., Matsa, E., Wu, H., Ong, S.-G., Sharma, A., Holmström, A., Chang, A. C., Coronado, M. J., Ebert, A. D., et al. (2016) · Nature Medicine · doi:10.1038/nm.4087 · Cited by 742
Campisi, M., Shin, Y., Osaki, T., Hajal, C., Chiono, V., & Kamm, R. D. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.014 · Cited by 718
Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
Schaaf, M. B., Garg, A. D., & Agostinis, P. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0061-0 · Cited by 629
Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
Jenkins, R. W., Aref, A. R., Lizotte, P. H., Ivanova, E., Stinson, S., Zhou, C. W., Bowden, M., Deng, J., Liu, H., Miao, D., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0833 · Cited by 594
Rajan, N., Habermehl, J., Coté, M.-F., Doillon, C. J., & Mantovani, D. (2006) · Nature Protocols · doi:10.1038/nprot.2006.430 · Cited by 577
The hallmarks of successful anticancer immunotherapy
Galluzzi, L., Chan, T. A., Kroemer, G., Wolchok, J. D., & López-Soto, A. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat7807 · Cited by 575
A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone
Bersini, S., Jeon, J. S., Dubini, G., Arrigoni, C., Chung, S., Charest, J. L., Moretti, M., & Kamm, R. D. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.050 · Cited by 534
Herland, A., Maoz, B. M., Das, D., Somayaji, M. R., Prantil-Baun, R., Novak, R., Cronce, M., Huffstater, T., Jeanty, S. S. F., Ingram, M., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0498-9 · Cited by 500
Organoid and Spheroid Tumor Models: Techniques and Applications
Gunti, S., Hoke, A. T. K., Vu, K. P., & London, N. R. (2021) · Cancers · doi:10.3390/cancers13040874 · Cited by 479
Hassell, B. A., Goyal, G., Lee, E., Sontheimer-Phelps, A., Levy, O., Chen, C. S., & Ingber, D. E. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.043 · Cited by 467
An overview of targeted cancer therapy
Padma, V. V. (2015) · BioMedicine · doi:10.7603/s40681-015-0019-4 · Cited by 459
Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids
Schuster, B., Junkin, M., Kashaf, S. S., Romero-Calvo, I., Kirby, K., Matthews, J., Weber, C. R., Rzhetsky, A., White, K. P., & Tay, S. (2020) · Nature Communications · doi:10.1038/s41467-020-19058-4 · Cited by 424
The production of 3D tumor spheroids for cancer drug discovery
Sant, S., & Johnston, P. A. (2017) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2017.03.002 · Cited by 404
Pelon, F., Bourachot, B., Kieffer, Y., Magagna, I., Mermet-Meillon, F., Bonnet, I., Costa, A., Givel, A.-M., Attieh, Y., Barbazan, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14134-w · Cited by 390
Self-citationChen, M. B., Whisler, J. A., Fröse, J., Yu, C., Shin, Y., & Kamm, R. D. (2017) · Nature Protocols · doi:10.1038/nprot.2017.018 · Cited by 385
Organ-on-a-chip platforms for studying drug delivery systems
Bhise, N. S., Ribas, J., Manoharan, V., Zhang, Y. S., Polini, A., Massa, S., Dokmeci, M. R., & Khademhosseini, A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.004 · Cited by 381
Oriented collagen fibers direct tumor cell intravasation
Han, W., Chen, S., Yuan, W., Fan, Q., Tian, J., Wang, X., Chen, L., Zhang, X., Wei, W., Liu, R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610347113 · Cited by 376
Tumour-on-a-chip provides an optical window into nanoparticle tissue transport
Albanese, A., Lam, A. K., Sykes, E. A., Rocheleau, J. V., & Chan, W. C. W. (2013) · Nature Communications · doi:10.1038/ncomms3718 · Cited by 330
A vascularized and perfused organ-on-a-chip platform for large-scale drug screening applications
Phan, D. T. T., Wang, X., Craver, B. M., Sobrino, A., Zhao, D., Chen, J. C., Lee, L. Y. N., George, S. C., Lee, A. P., & Hughes, C. C. W. (2017) · Lab on a Chip · doi:10.1039/c6lc01422d · Cited by 325
Self-citationOn-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology
Chou, D. B., Frismantas, V., Milton, Y., David, R., Pop-Damkov, P., Ferguson, D., MacDonald, A., Vargel Bölükbaşı, Ö., Joyce, C. E., Moreira Teixeira, L. S., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0495-z · Cited by 294
Compressive Stress Inhibits Proliferation in Tumor Spheroids through a Volume Limitation
Delarue, M., Montel, F., Vignjevic, D., Prost, J., Joanny, J.-F., & Cappello, G. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.08.031 · Cited by 287
Jeong, S.-Y., Lee, J.-H., Shin, Y., Chung, S., & Kuh, H.-J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0159013 · Cited by 287
The Influence of Metabolism on Drug Response in Cancer
Zaal, E. A., & Berkers, C. R. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00500 · Cited by 272
Biologics vs. small molecules: Drug costs and patient access
Makurvet, F. D. (2021) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2020.100075 · Cited by 271
A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors
Pavesi, A., Tan, A. T., Koh, S., Chia, A., Colombo, M., Antonecchia, E., Miccolis, C., Ceccarello, E., Adriani, G., Raimondi, M. T., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.89762 · Cited by 241
Strianese, O., Rizzo, F., Ciccarelli, M., Galasso, G., D’Agostino, Y., Salvati, A., Del Giudice, C., Tesorio, P., & Rusciano, M. R. (2020) · Genes · doi:10.3390/genes11070747 · Cited by 241
A microfluidics platform for combinatorial drug screening on cancer biopsies
Eduati, F., Utharala, R., Madhavan, D., Neumann, U. P., Longerich, T., Cramer, T., Saez-Rodriguez, J., & Merten, C. A. (2018) · Nature Communications · doi:10.1038/s41467-018-04919-w · Cited by 239
Nicolò, E., Giugliano, F., Ascione, L., Tarantino, P., Corti, C., Tolaney, S. M., Cristofanilli, M., & Curigliano, G. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102395 · Cited by 236
Kiriiri, G. K., Njogu, P. M., & Mwangi, A. N. (2020) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-020-00047-9 · Cited by 227
A microengineered pathophysiological model of early-stage breast cancer
Choi, Y., Hyun, E., Seo, J., Blundell, C., Kim, H. C., Lee, E., Lee, S. H., Moon, A., Moon, W. K., & Huh, D. (2015) · Lab on a Chip · doi:10.1039/c5lc00514k · Cited by 222
Digital twins for predictive oncology will be a paradigm shift for precision cancer care
Hernandez-Boussard, T., Macklin, P., Greenspan, E. J., Gryshuk, A. L., Stahlberg, E., Syeda-Mahmood, T., & Shmulevich, I. (2021) · Nature Medicine · doi:10.1038/s41591-021-01558-5 · Cited by 219
In vitro cancer cell–ECM interactions inform in vivo cancer treatment
Holle, A. W., Young, J. L., & Spatz, J. P. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.007 · Cited by 213
Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model
Zhang, Z., Shiratsuchi, H., Lin, J., Chen, G., Reddy, R. M., Azizi, E., Fouladdel, S., Chang, A. C., Lin, L., Jiang, H., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2592 · Cited by 207
Grassart, A., Malardé, V., Gobaa, S., Sartori-Rupp, A., Kerns, J., Karalis, K., Marteyn, B., Sansonetti, P., & Sauvonnet, N. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.08.007 · Cited by 206
Ko, J., Ahn, J., Kim, S., Lee, Y., Lee, J., Park, D., & Jeon, N. L. (2019) · Lab on a Chip · doi:10.1039/c9lc00140a · Cited by 205
Multi-organ system for the evaluation of efficacy and off-target toxicity of anticancer therapeutics
McAleer, C. W., Long, C. J., Elbrecht, D., Sasserath, T., Bridges, L. R., Rumsey, J. W., Martin, C., Schnepper, M., Wang, Y., Schuler, F., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav1386 · Cited by 199
A Tumor‐on‐a‐Chip System with Bioprinted Blood and Lymphatic Vessel Pair
Cao, X., Ashfaq, R., Cheng, F., Maharjan, S., Li, J., Ying, G., Hassan, S., Xiao, H., Yue, K., & Zhang, Y. S. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201807173 · Cited by 198
A Spontaneous 3D Bone‐On‐a‐Chip for Bone Metastasis Study of Breast Cancer Cells
Hao, S., Ha, L., Cheng, G., Wan, Y., Xia, Y., Sosnoski, D. M., Mastro, A. M., & Zheng, S. (2018) · Small · doi:10.1002/smll.201702787 · Cited by 195
Oxygen control with microfluidics
Brennan, M. D., Rexius-Hall, M. L., Elgass, L. J., & Eddington, D. T. (2014) · Lab Chip · doi:10.1039/c4lc00853g · Cited by 188
Nguyen, M., De Ninno, A., Mencattini, A., Mermet-Meillon, F., Fornabaio, G., Evans, S. S., Cossutta, M., Khira, Y., Han, W., Sirven, P., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.12.015 · Cited by 184
Self-citationTrujillo-de Santiago, G., Flores-Garza, B. G., Tavares-Negrete, J. A., Lara-Mayorga, I. M., González-Gamboa, I., Zhang, Y. S., Rojas-Martínez, A., Ortiz-López, R., & Álvarez, M. M. (2019) · Materials · doi:10.3390/ma12182945 · Cited by 184
Micro-dissected tumor tissues on chip: an ex vivo method for drug testing and personalized therapy
Astolfi, M., Péant, B., Lateef, M. A., Rousset, N., Kendall-Dupont, J., Carmona, E., Monet, F., Saad, F., Provencher, D., Mes-Masson, A.-M., et al. (2016) · Lab on a Chip · doi:10.1039/c5lc01108f · Cited by 182
Parlato, S., De Ninno, A., Molfetta, R., Toschi, E., Salerno, D., Mencattini, A., Romagnoli, G., Fragale, A., Roccazzello, L., Buoncervello, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01013-x · Cited by 181
Satoh, T., Sugiura, S., Shin, K., Onuki-Nagasaki, R., Ishida, S., Kikuchi, K., Kakiki, M., & Kanamori, T. (2018) · Lab on a Chip · doi:10.1039/c7lc00952f · Cited by 181
Surface characterization of extracellular matrix scaffolds
Brown, B. N., Barnes, C. A., Kasick, R. T., Michel, R., Gilbert, T. W., Beer-Stolz, D., Castner, D. G., Ratner, B. D., & Badylak, S. F. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.061 · Cited by 180
A one-stop microfluidic-based lung cancer organoid culture platform for testing drug sensitivity
Jung, D. J., Shin, T. H., Kim, M., Sung, C. O., Jang, S. J., & Jeong, G. S. (2019) · Lab on a Chip · doi:10.1039/c9lc00496c · Cited by 176
Ayuso, J. M., Rehman, S., Virumbrales-Munoz, M., McMinn, P. H., Geiger, P., Fitzgerald, C., Heaster, T., Skala, M. C., & Beebe, D. J. (2021) · Science Advances · doi:10.1126/sciadv.abc2331 · Cited by 176
From Donor to the Lab: A Fascinating Journey of Primary Cell Lines
Richter, M., Piwocka, O., Musielak, M., Piotrowski, I., Suchorska, W. M., & Trzeciak, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.711381 · Cited by 174
Khoo, B. L., Grenci, G., Lim, Y. B., Lee, S. C., Han, J., & Lim, C. T. (2018) · Nature Protocols · doi:10.1038/nprot.2017.125 · Cited by 172
A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling
Nguyen, D.-H. T., Lee, E., Alimperti, S., Norgard, R. J., Wong, A., Lee, J. J.-K., Eyckmans, J., Stanger, B. Z., & Chen, C. S. (2019) · Science Advances · doi:10.1126/sciadv.aav6789 · Cited by 172
Microfluidics Enabled Bottom-Up Engineering of 3D Vascularized Tumor for Drug Discovery
Agarwal, P., Wang, H., Sun, M., Xu, J., Zhao, S., Liu, Z., Gooch, K. J., Zhao, Y., Lu, X., & He, X. (2017) · ACS Nano · doi:10.1021/acsnano.7b00824 · Cited by 168
Cell Viability Assays -- Assay Guidance Manual
Gs, S., Grossman, A., Brimacombe, K. R., Arkin, M. R., Auld, D., Austin, C. P., Baell, J. B., Bejcek, B. E., Jmm, C., Tdy, C., et al. (2004) · Cited by 165
Simulation of complex transport of nanoparticles around a tumor using tumor-microenvironment-on-chip
Kwak, B., Ozcelikkale, A., Shin, C. S., Park, K., & Han, B. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.027 · Cited by 165
Cui, X., Ma, C., Vasudevaraja, V., Serrano, J., Tong, J., Peng, Y., Delorenzo, M., Shen, G., Frenster, J., Morales, R.-T. T., et al. (2020) · eLife · doi:10.7554/elife.52253 · Cited by 163
Aleman, J., & Skardal, A. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26871 · Cited by 160
The effects of monocytes on tumor cell extravasation in a 3D vascularized microfluidic model
Boussommier-Calleja, A., Atiyas, Y., Haase, K., Headley, M., Lewis, C., & Kamm, R. D. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.005 · Cited by 158
Laser Photoablation of Guidance Microchannels into Hydrogels Directs Cell Growth in Three Dimensions
Sarig-Nadir, O., Livnat, N., Zajdman, R., Shoham, S., & Seliktar, D. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.03.019 · Cited by 155
Chang, C.-W., Cheng, Y.-J., Tu, M., Chen, Y.-H., Peng, C.-C., Liao, W.-H., & Tung, Y.-C. (2014) · Lab Chip · doi:10.1039/c4lc00732h · Cited by 154
Patient-Derived Cancer Organoids as Predictors of Treatment Response
Verduin, M., Hoeben, A., Ruysscher, D. D., & Vooijs, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.641980 · Cited by 148
A three dimensional micropatterned tumor model for breast cancer cell migration studies
Peela, N., Sam, F. S., Christenson, W., Truong, D., Watson, A. W., Mouneimne, G., Ros, R., & Nikkhah, M. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.039 · Cited by 147
Lu, S., Cuzzucoli, F., Jiang, J., Liang, L.-G., Wang, Y., Kong, M., Zhao, X., Cui, W., Li, J., & Wang, S. (2018) · Lab on a Chip · doi:10.1039/c8lc00852c · Cited by 144
Lee, J., Mehrotra, S., Zare‐Eelanjegh, E., Rodrigues, R. O., Akbarinejad, A., Ge, D., Amato, L., Kiaee, K., Fang, Y., Rosenkranz, A., et al. (2021) · Small · doi:10.1002/smll.202004258 · Cited by 143
Evaluating natural killer cell cytotoxicity against solid tumors using a microfluidic model
Ayuso, J. M., Truttschel, R., Gong, M. M., Humayun, M., Virumbrales-Munoz, M., Vitek, R., Felder, M., Gillies, S. D., Sondel, P., Wisinski, K. B., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2018.1553477 · Cited by 142
Isolated tumor endothelial cells maintain specific character during long-term culture
Matsuda, K., Ohga, N., Hida, Y., Muraki, C., Tsuchiya, K., Kurosu, T., Akino, T., Shih, S., Totsuka, Y., Klagsbrun, M., et al. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.089 · Cited by 137
Patient-derived pancreatic cancer-on-a-chip recapitulates the tumor microenvironment
Haque, M. R., Wessel, C. R., Leary, D. D., Wang, C., Bhushan, A., & Bishehsari, F. (2022) · Microsystems & Nanoengineering · doi:10.1038/s41378-022-00370-6 · Cited by 137
Development and characterization of a microfluidic model of the tumour microenvironment
Ayuso, J. M., Virumbrales-Muñoz, M., Lacueva, A., Lanuza, P. M., Checa-Chavarria, E., Botella, P., Fernández, E., Doblare, M., Allison, S. J., Phillips, R. M., et al. (2016) · Scientific Reports · doi:10.1038/srep36086 · Cited by 134
Live-Cell Imaging of Invasion and Intravasation in an Artificial Microvessel Platform
Wong, A. D., & Searson, P. C. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1042 · Cited by 132
Atkins, J. T., George, G. C., Hess, K., Marcelo-Lewis, K. L., Yuan, Y., Borthakur, G., Khozin, S., LoRusso, P., & Hong, D. S. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01033-x · Cited by 132
Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress
Ip, C. K. M., Li, S.-S., Tang, M. Y. H., Sy, S. K. H., Ren, Y., Shum, H. C., & Wong, A. S. T. (2016) · Scientific Reports · doi:10.1038/srep26788 · Cited by 128
Cancer-on-a-chip systems at the frontier of nanomedicine
Zhang, Y. S., Zhang, Y.-N., & Zhang, W. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.03.011 · Cited by 127
Endothelial Regulation of Drug Transport in a 3D Vascularized Tumor Model
Haase, K., Offeddu, G. S., Gillrie, M. R., & Kamm, R. D. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202002444 · Cited by 127
Akkın, S., Varan, G., & Bilensoy, E. (2021) · Molecules · doi:10.3390/molecules26113382 · Cited by 127
Romero-López, M., Trinh, A. L., Sobrino, A., Hatch, M. M. S., Keating, M. T., Fimbres, C., Lewis, D. E., Gershon, P. D., Botvinick, E. L., Digman, M., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.034 · Cited by 125
Evaluating Biomaterial- and Microfluidic-Based 3D Tumor Models
Carvalho, M. R., Lima, D., Reis, R. L., Correlo, V. M., & Oliveira, J. M. (2015) · Trends in biotechnology · doi:10.1016/j.tibtech.2015.09.009 · Cited by 122
Metastasis in context: modeling the tumor microenvironment with cancer-on-a-chip approaches
Sleeboom, J. J. F., Eslami Amirabadi, H., Nair, P., Sahlgren, C. M., & den Toonder, J. M. J. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.033100 · Cited by 122
Microfluidic Arrays of Breast Tumor Spheroids for Drug Screening and Personalized Cancer Therapies
Prince, E., Kheiri, S., Wang, Y., Xu, F., Cruickshank, J., Topolskaia, V., Tao, H., Young, E. W. K., McGuigan, A. P., Cescon, D. W., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202101085 · Cited by 121
Integrated heart/cancer on a chip to reproduce the side effects of anti-cancer drugs in vitro
Kamei, K.-I., Kato, Y., Hirai, Y., Ito, S., Satoh, J., Oka, A., Tsuchiya, T., Chen, Y., & Tabata, O. (2017) · RSC Advances · doi:10.1039/c7ra07716e · Cited by 113
Sun, J., Masterman-Smith, M. D., Graham, N. A., Jiao, J., Mottahedeh, J., Laks, D. R., Ohashi, M., DeJesus, J., Kamei, K.-I., Lee, K.-B., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0076 · Cited by 112
Tensile Forces Originating from Cancer Spheroids Facilitate Tumor Invasion
Kopanska, K. S., Alcheikh, Y., Staneva, R., Vignjevic, D., & Betz, T. (2016) · PLOS ONE · doi:10.1371/journal.pone.0156442 · Cited by 112
Behavior of HepG2/C3A cell cultures in a microfluidic bioreactor
Baudoin, R., Griscom, L., Prot, J. M., Legallais, C., & Leclerc, É. (2010) · Biochemical Engineering Journal · doi:10.1016/j.bej.2010.10.007 · Cited by 111
Microfluidic model of ductal carcinoma in situ with 3D, organotypic structure
Bischel, L. L., Beebe, D. J., & Sung, K. E. (2015) · BMC Cancer · doi:10.1186/s12885-015-1007-5 · Cited by 110
A 3D human renal cell carcinoma-on-a-chip for the study of tumor angiogenesis
Miller, C. P., Tsuchida, C., Zheng, Y., Himmelfarb, J., & Akilesh, S. (2018) · Neoplasia · doi:10.1016/j.neo.2018.02.011 · Cited by 105
Methods to study the tumor microenvironment under controlled oxygen conditions
Byrne, M. B., Leslie, M. T., Gaskins, H. R., & Kenis, P. J. A. (2014) · Trends in Biotechnology · doi:10.1016/j.tibtech.2014.09.006 · Cited by 104
Circulatory shear flow alters the viability and proliferation of circulating colon cancer cells
Fan, R., Emery, T., Zhang, Y., Xia, Y., Sun, J., & Wan, J. (2016) · Scientific Reports · doi:10.1038/srep27073 · Cited by 103
Implementing oxygen control in chip-based cell and tissue culture systems
Oomen, P. E., Skolimowski, M. D., & Verpoorte, E. (2016) · Lab on a Chip · doi:10.1039/c6lc00772d · Cited by 103
Tang, Y., Soroush, F., Sheffield, J. B., Wang, B., Prabhakarpandian, B., & Kiani, M. F. (2017) · Scientific Reports · doi:10.1038/s41598-017-09815-9 · Cited by 102
Tumor-on-a-chip: a microfluidic model to study cell response to environmental gradients
Ayuso, J. M., Virumbrales-Munoz, M., McMinn, P. H., Rehman, S., Gomez, I., Karim, M. R., Trusttchel, R., Wisinski, K. B., Beebe, D. J., & Skala, M. C. (2019) · Lab on a Chip · doi:10.1039/c9lc00270g · Cited by 100
What Is the Right Dose? The Elusive Optimal Biologic Dose in Phase I Clinical Trials
Adjei, A. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.4658 · Cited by 97
Stretching Fibroblasts Remodels Fibronectin and Alters Cancer Cell Migration
Ao, M., Brewer, B. M., Yang, L., Franco Coronel, O. E., Hayward, S. W., Webb, D. J., & Li, D. (2015) · Scientific Reports · doi:10.1038/srep08334 · Cited by 96
A Microvascularized Tumor-mimetic Platform for Assessing Anti-cancer Drug Efficacy
Pradhan, S., Smith, A. M., Garson, C. J., Hassani, I., Seeto, W. J., Pant, K., Arnold, R. D., Prabhakarpandian, B., & Lipke, E. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-21075-9 · Cited by 96
Immunocompetent cancer-on-chip models to assess immuno-oncology therapy
Maulana, T. I., Kromidas, E., Wallstabe, L., Cipriano, M., Alb, M., Zaupa, C., Hudecek, M., Fogal, B., & Loskill, P. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.015 · Cited by 93
Strelez, C., Chilakala, S., Ghaffarian, K., Lau, R., Spiller, E. R., Ung, N. M., Hixon, D., Yoon, A. Y., Sun, R., Lenz, H., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102509 · Cited by 92
Cancer-driven dynamics of immune cells in a microfluidic environment
Agliari, E., Biselli, E., De Ninno, A., Schiavoni, G., Gabriele, L., Gerardino, A., Mattei, F., Barra, A., & Businaro, L. (2014) · Scientific Reports · doi:10.1038/srep06639 · Cited by 91
Nothdurfter, D., Ploner, C., Coraça-Huber, D. C., Wilflingseder, D., Müller, T., Hermann, M., Hagenbuchner, J., & Ausserlechner, M. J. (2022) · Biofabrication · doi:10.1088/1758-5090/ac5fb7 · Cited by 90
Multiplexed drug testing of tumor slices using a microfluidic platform
Horowitz, L. F., Rodriguez, A. D., Dereli-Korkut, Z., Lin, R., Castro, K., Mikheev, A. M., Monnat, R. J., Folch, A., & Rostomily, R. C. (2020) · npj Precision Oncology · doi:10.1038/s41698-020-0117-y · Cited by 88
Translational Roadmap for the Organs-on-a-Chip Industry toward Broad Adoption
Allwardt, V., Ainscough, A. J., Viswanathan, P., Sherrod, S. D., McLean, J. A., Haddrick, M., & Pensabene, V. (2020) · Bioengineering · doi:10.3390/bioengineering7030112 · Cited by 88
Song, J., Miermont, A., Lim, C. T., & Kamm, R. D. (2018) · Scientific Reports · doi:10.1038/s41598-018-36381-5 · Cited by 87
Fundamentals of Laser‐Based Hydrogel Degradation and Applications in Cell and Tissue Engineering
Pradhan, S., Keller, K. A., Sperduto, J. L., & Slater, J. H. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700681 · Cited by 86
Engineering a 3D microfluidic culture platform for tumor-treating field application
Pavesi, A., Adriani, G., Tay, A., Warkiani, M. E., Yeap, W. H., Wong, S. C., & Kamm, R. D. (2016) · Scientific Reports · doi:10.1038/srep26584 · Cited by 84
New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay
Wan, Z., Floryan, M. A., Coughlin, M. F., Zhang, S., Zhong, A. X., Shelton, S. E., Wang, X., Xu, C., Barbie, D. A., & Kamm, R. D. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202201784 · Cited by 84
Li, Z.-L., Wang, Z., Wei, G., Yang, Y., & Wang, X. (2020) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v12.i3.267 · Cited by 82
Ronteix, G., Jain, S., Angély, C., Cazaux, M., Khazen, R., Bousso, P., & Baroud, C. N. (2022) · Nature Communications · doi:10.1038/s41467-022-30575-2 · Cited by 79
Zheng, L., Wang, B., Sun, Y., Dai, B., Fu, Y., Zhang, Y., Wang, Y., Yang, Z., Sun, Z., Zhuang, S., et al. (2021) · ACS Sensors · doi:10.1021/acssensors.0c01846 · Cited by 78
Wang, X.-Y., Pei, Y., Xie, M., Jin, Z.-H., Xiao, Y.-S., Wang, Y., Zhang, L.-N., Li, Y., & Huang, W.-H. (2015) · Lab on a Chip · doi:10.1039/c4lc00973h · Cited by 77
An, D., Kim, K., & Kim, J. (2014) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2014.078 · Cited by 77
3D Culture as a Clinically Relevant Model for Personalized Medicine
Fong, E. L. S., Toh, T. B., Yu, H., & Chow, E. K. (2017) · SLAS TECHNOLOGY · doi:10.1177/2472630317697251 · Cited by 77
A microfluidic platform for functional testing of cancer drugs on intact tumor slices
Rodriguez, A. D., Horowitz, L. F., Castro, K., Kenerson, H., Bhattacharjee, N., Gandhe, G., Raman, A., Monnat, R. J., Yeung, R., Rostomily, R. C., et al. (2020) · Lab on a Chip · doi:10.1039/c9lc00811j · Cited by 77
Enabling peristalsis of human colon tumor organoids on microfluidic chips
Fang, G., Lu, H., Al-Nakashli, R., Chapman, R., Zhang, Y., Ju, L. A., Lin, G., Stenzel, M. H., & Jin, D. (2022) · Biofabrication · doi:10.1088/1758-5090/ac2ef9 · Cited by 77
Mencattini, A., Giuseppe, D. D., Comes, M. C., Casti, P., Corsi, F., Bertani, F. R., Ghibelli, L., Businaro, L., Natale, C. D., Parrini, M. C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-64246-3 · Cited by 75
Self-citationAn Ex Vivo Platform for the Prediction of Clinical Response in Multiple Myeloma
Silva, A., Silva, M. C., Sudalagunta, P. R., Graeter, A. I., Jacobson, T., Collins, A., Nguyen, T., Song, J., Chen, D., Chen, L., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0502 · Cited by 74
Tumour-on-chip microfluidic platform for assessment of drug pharmacokinetics and treatment response
Petreuş, T., Cadogan, E. B., Hughes, G. D., Smith, A., Reddy, V. P., Lau, A., O’Connor, M. J., Critchlow, S. E., Ashford, M. B., & O’Connor, L. O. (2021) · Communications Biology · doi:10.1038/s42003-021-02526-y · Cited by 74
Immune Organs and Immune Cells on a Chip: An Overview of Biomedical Applications
Morsink, M., Willemen, N., Leijten, J., Bansal, R., & Shin, S. (2020) · Micromachines · doi:10.3390/mi11090849 · Cited by 73
An in vitro vascular chip using 3D printing-enabled hydrogel casting
Yang, L., Shridhar, S. V., Gerwitz, M., & Soman, P. (2016) · Biofabrication · doi:10.1088/1758-5090/8/3/035015 · Cited by 72
Mechanical Control of Cell Proliferation Increases Resistance to Chemotherapeutic Agents
Rizzuti, I. F., Mascheroni, P., Arcucci, S., Ben-Mériem, Z., Prunet, A., Barentin, C., Rivière, C., Delanoë-Ayari, H., Hatzikirou, H., Guillermet-Guibert, J., et al. (2020) · Physical Review Letters · doi:10.1103/physrevlett.125.128103 · Cited by 72
Bai, J., Tu, T.-Y., Kim, C., Thiery, J. P., & Kamm, R. D. (2015) · Oncotarget · doi:10.18632/oncotarget.5464 · Cited by 70
Tumor-on-a-chip platform to interrogate the role of macrophages in tumor progression
Bi, Y., Shirure, V. S., Liu, R., Cunningham, C., Ding, L., Meacham, J. M., Goedegebuure, S. P., George, S. C., & Fields, R. C. (2020) · Integrative Biology · doi:10.1093/intbio/zyaa017 · Cited by 70
Adjei‐Sowah, E., O’Connor, S. A., Veldhuizen, J., Cascio, C. L., Plaisier, C. L., Mehta, S. V., & Nikkhah, M. (2022) · Advanced Science · doi:10.1002/advs.202201436 · Cited by 69
Hajal, C., Ibrahim, L., Serrano, J. C., Offeddu, G. S., & Kamm, R. D. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120470 · Cited by 68
Tumor-on-a-chip platforms to study cancer–immune system crosstalk in the era of immunotherapy
Parlato, S., Grisanti, G., Sinibaldi, G., Peruzzi, G., Casciola, C. M., & Gabriele, L. (2021) · Lab on a Chip · doi:10.1039/d0lc00799d · Cited by 66
Engineering tumor vasculature on an injection-molded plastic array 3D culture (IMPACT) platform
Lee, S., Lim, J., Yu, J., Ahn, J., Lee, Y., & Jeon, N. L. (2019) · Lab on a Chip · doi:10.1039/c9lc00148d · Cited by 65
Drifka, C. R., Eliceiri, K. W., Weber, S. M., & Kao, W. J. (2013) · Lab on a Chip · doi:10.1039/c3lc50487e · Cited by 64
Chi, C., Lao, Y., Ahmed, A. H. R., Benoy, E. C., Li, C., Dereli‐Korkut, Z., Fu, B. M., Leong, K. W., & Wang, S. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000880 · Cited by 64
Kim, D., Hwang, K. S., Seo, E. U., Seo, S., Lee, B. C., Choi, N., Choi, J., & Kim, H. N. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102581 · Cited by 63
Three Dimensional Microfluidic Cell Arrays for ex Vivo Drug Screening with Mimicked Vascular Flow
Dereli-Korkut, Z., Akaydin, H. D., Ahmed, A. H. R., Jiang, X., & Wang, S. (2014) · Analytical Chemistry · doi:10.1021/ac403899j · Cited by 62
A microfluidic cancer-on-chip platform predicts drug response using organotypic tumor slice culture
Chakrabarty, S., Quiros-Solano, W. F., Kuijten, M. M. P., Haspels, B., Mallya, S., Lo, C. S. Y., Othman, A., Silvestri, C., van de Stolpe, A., Gaio, N., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-0799 · Cited by 61
Cancer‐on‐a‐Chip for Modeling Immune Checkpoint Inhibitor and Tumor Interactions
Jiang, X., Ren, L. M., Tebon, P. J., Wang, C., Zhou, X., Qu, M., Zhu, J., Ling, H., Zhang, S., Xue, Y., et al. (2021) · Small · doi:10.1002/smll.202004282 · Cited by 60
Liu, W., Wang, J.-C., & Wang, J. (2015) · Lab on a Chip · doi:10.1039/c4lc01242a · Cited by 59
Translational Medicine Guide transforms drug development processes: the recent Merck experience
Dolgos, H., Trusheim, M. R., Groß, D., Halle, J.-P., Ogden, J., Osterwalder, B., Sedman, E., & Rossetti, L. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.003 · Cited by 58
Adoption of organ-on-chip platforms by the pharmaceutical industry
Vulto, P., & Joore, J. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00323-0 · Cited by 58
Hattersley, S. M., Sylvester, D. C., Dyer, C. E., Stafford, N. D., Haswell, S. J., & Greenman, J. (2012) · Annals of Biomedical Engineering · doi:10.1007/s10439-011-0428-9 · Cited by 55
A Preclinical Assay for Chemosensitivity in Multiple Myeloma
Khin, Z. P., Ribeiro, M. L. C., Jacobson, T., Hazlehurst, L., Perez, L., Baz, R., Shain, K., & Silva, A. S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2397 · Cited by 55
Metabolic Switching of Tumor Cells under Hypoxic Conditions in a Tumor-on-a-chip Model
Palacio-Castañeda, V., Kooijman, L. J., Venzac, B., Verdurmen, W. P. R., & Gac, S. L. (2020) · Micromachines · doi:10.3390/mi11040382 · Cited by 55
Gerigk, M., Bulstrode, H. J. C. J., Shi, H., Tönisen, F., Cerutti, C., Morrison, G. M., Rowitch, D. H., & Huang, Y. Y. S. (2021) · Lab on a Chip · doi:10.1039/d1lc00271f · Cited by 55
Koens, R., Tabata, Y., Serrano, J. C., Aratake, S., Yoshino, D., Kamm, R. D., & Funamoto, K. (2020) · APL Bioengineering · doi:10.1063/1.5127069 · Cited by 53
Dynamic Microenvironment Induces Phenotypic Plasticity of Esophageal Cancer Cells Under Flow
Calibasi Kocal, G., Güven, S., Foygel, K., Goldman, A., Chen, P., Sengupta, S., Paulmurugan, R., Baskin, Y., & Demirci, U. (2016) · Scientific Reports · doi:10.1038/srep38221 · Cited by 52
Evaluation of cancer immunotherapy using mini-tumor chips
Ao, Z., Cai, H., Wu, Z., Hu, L., Li, X., Kaurich, C., Gu, M., Cheng, L., Lu, X., & Guo, F. (2022) · Theranostics · doi:10.7150/thno.71761 · Cited by 52
Molecular cancer cell responses to solid compressive stress and interstitial fluid pressure
Purkayastha, P., Jaiswal, M. K., & Lele, T. P. (2021) · Cytoskeleton · doi:10.1002/cm.21680 · Cited by 51
Kramer, B., Haan, L. D., Vermeer, M., Olivier, T., Hankemeier, T., Vulto, P., Joore, J., & Lanz, H. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184647 · Cited by 50
In vitro bone metastasis dwelling in a 3D bioengineered niche
Han, W., Botty, R. E., Montaudon, É., Malaquin, L., Deschaseaux, F., Espagnolle, N., Marangoni, E., Cottu, P. H., Zalcman, G., Parrini, M. C., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120624 · Cited by 50
Self-citationMatrigel Basement Membrane Matrix influences expression of microRNAs in cancer cell lines
Price, K. J., Tsykin, A., Giles, K. M., Sladic, R. T., Epis, M. R., Ganss, R., Goodall, G. J., & Leedman, P. J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.09.059 · Cited by 49
Microfluidics for Cancer Nanomedicine: From Fabrication to Evaluation
Zhang, H., Zhu, Y., & Shen, Y. (2018) · Small · doi:10.1002/smll.201800360 · Cited by 49
Lab-on-a-chip systems for photodynamic therapy investigations
Chudy, M., Tokarska, K., Jastrzębska, E., Bułka, M., Drozdek, S., Lamch, Ł., Wilk, K. A., & Brzózka, Z. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.10.013 · Cited by 48
Bispecific Antibodies: A Smart Arsenal for Cancer Immunotherapies
You, G., Won, J., Lee, Y., Moon, D., Park, Y., Lee, S. H., & Lee, S.-W. (2021) · Vaccines · doi:10.3390/vaccines9070724 · Cited by 48
Tien, J., Truslow, J. G., & Nelson, C. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045191 · Cited by 46
Microfabricated blood vessels undergo neoangiogenesis
DiVito, K. A., Daniele, M. A.-A., Roberts, S. A., Ligler, F. S., & Adams, A. A. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.05.012 · Cited by 46
Humayun, M., Ayuso, J. M., Brenneke, R. A., Virumbrales-Muñoz, M., Lugo-Cintrón, K., Kerr, S., Ponik, S. M., & Beebe, D. J. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120640 · Cited by 46
Mitxelena-Iribarren, O., Zabalo, J., Arana, S., & Mujika, M. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.09.001 · Cited by 45
Controlled Drug Release and Chemotherapy Response in a Novel Acoustofluidic 3D Tumor Platform
Zervantonakis, I. K., & Arvanitis, C. D. (2016) · Small · doi:10.1002/smll.201503342 · Cited by 44
Evaluating Nanoparticles in Preclinical Research Using Microfluidic Systems
Zhu, D., Long, Q., Xu, Y., & Xing, J. (2019) · Micromachines · doi:10.3390/mi10060414 · Cited by 43
Ivanova, E., Kuraguchi, M., Xu, M., Portell, A. J., Taus, L., Diala, I., Lalani, A. S., Choi, J., Chambers, E. S., Li, S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1844 · Cited by 43
Frenkel, N. C., Poghosyan, S., Alarcon, C. R., García, S. B., Queiroz, K. C. S., van den Bent, L., Laoukili, J., Rinkes, I. H. M. B., Vulto, P., Kranenburg, O., et al. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01378 · Cited by 43
Dorrigiv, D., Simeone, K., Communal, L., Kendall‐Dupont, J., St‐Georges‐Robillard, A., Péant, B., Carmona, E., Mes‐Masson, A., & Gervais, T. (2021) · Cancers · doi:10.3390/cancers13164208 · Cited by 43
Mencattini, A., Lansche, C., Veith, I., Erbs, P., Balloul, J., Quéméneur, É., Descroix, S., Mechta‐Grigoriou, F., Zalcman, G., Zaupa, C., et al. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114571 · Cited by 43
Self-citationMicrofluidic system for modelling 3D tumour invasion into surrounding stroma and drug screening
Du, Z., Mi, S., Yi, X., Xu, Y., & Sun, W. (2018) · Biofabrication · doi:10.1088/1758-5090/aac70c · Cited by 42
Hydrogel microfluidic co‐culture device for photothermal therapy and cancer migration
Lee, J. M., Seo, H. I., Bae, J. H., & Chung, B. G. (2017) · Electrophoresis · doi:10.1002/elps.201600540 · Cited by 41
A Systematic Review of the Efficacy of Preclinical Models of Lung Cancer Drugs
Pan, E., Bogumil, D. D., Cortessis, V. K., Yu, S., & Nieva, J. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00591 · Cited by 39
Rapid multilayer microfabrication for modeling organotropic metastasis in breast cancer
Kwak, T. J., & Lee, E. (2020) · Biofabrication · doi:10.1088/1758-5090/abbd28 · Cited by 39
Virumbrales-Muñoz, M., Chen, J., Ayuso, J., Lee, M., Abel, E. J., & Beebe, D. J. (2020) · Lab on a Chip · doi:10.1039/d0lc00252f · Cited by 39
Investigation of Tumor Cell Behaviors on a Vascular Microenvironment-Mimicking Microfluidic Chip
Huang, R., Zheng, W., Liu, W., Zhang, W., Long, Y., & Jiang, X. (2015) · Scientific Reports · doi:10.1038/srep17768 · Cited by 38
Hou, Y., Ai, X., Zhao, L., Gao, Z., Wang, Y., Lu, Y., Tu, P., & Jiang, Y. (2020) · Lab on a Chip · doi:10.1039/d0lc00288g · Cited by 38
Azadi, S., Tafazzoli‐Shadpour, M., & Warkiani, M. E. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27612 · Cited by 38
Guerrero, Y. A., Desai, D., Sullivan, C., Kindt, E. K., Spilker, M. E., Maurer, T. S., Solomon, D. E., & Bartlett, D. W. (2020) · The AAPS Journal · doi:10.1208/s12248-020-0430-y · Cited by 37
Sliding walls: a new paradigm for fluidic actuation and protocol implementation in microfluidics
Venzac, B., Liu, Y., Ferrante, I., Vargas, P., Yamada, A., Courson, R., Verhulsel, M., Malaquin, L., Viovy, J., & Descroix, S. (2020) · Microsystems & Nanoengineering · doi:10.1038/s41378-019-0125-7 · Cited by 36
Self-citationMyCTC chip: microfluidic-based drug screen with patient-derived tumour cells from liquid biopsies
Schwab, F. D., Scheidmann, M. C., Ozimski, L. L., Kling, A., Armbrecht, L., Ryser, T., Krol, I., Strittmatter, K., Nguyen-Sträuli, B. D., Jacob, F., et al. (2022) · Microsystems & Nanoengineering · doi:10.1038/s41378-022-00467-y · Cited by 36
An Overview of the Role of Mechanical Stretching in the Progression of Lung Cancer
Gong, F., Yang, Y., Wen, L., Wang, C., Li, J., & Dai, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.781828 · Cited by 35
Is Curcumin the Answer to Future Chemotherapy Cocktail?
Kong, W. Y., Ngai, S. C., Goh, B. H., Lee, L., Htar, T. T., & Chuah, L. (2021) · Molecules · doi:10.3390/molecules26144329 · Cited by 33
Gioeli, D., Snow, C. J., Simmers, M. B., Hoang, S. A., Figler, R. A., Allende, J. A., Roller, D. G., Parsons, J. T., Wulfkuhle, J. D., Petricoin, E. F., et al. (2019) · Lab on a Chip · doi:10.1039/c8lc00755a · Cited by 31
Ong, L. J. Y., Chia, S., Wong, S. Q. R., Zhang, X., Chua, H., Loo, J. M., Chua, W. Y., Chua, C., Tan, E., Hentze, H., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.952726 · Cited by 31
A Flexible Microdevice for Mechanical Cell Stimulation and Compression in Microfluidic Settings
Onal, S., Alkaisi, M. M., & Nock, V. (2021) · Frontiers in Physics · doi:10.3389/fphy.2021.654918 · Cited by 29
Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept
Puch, C. B. M. D., Vanderstraete, M., Giraud, S., Lautrette, C., Christou, N., & Mathonnet, M. (2021) · Theranostics · doi:10.7150/thno.55954 · Cited by 29
Research works printed but not linked: 6
- T. C. Chang, A. M. Mikheev, W. Huynh, R. J. Monnat, R. C. Rostomily and A. Folch, Parallel Microfluidic Chemosensitivity Testing on Individual Slice Cultures, Lab Chip, 2014, 14(23), 4540-4551, DOI: 10.1039/b000000x/NIH. · doi:10.1039/b000000x/nih
- W. Han, S. Chen and W. Yuan, et al., Oriented collagen fibers direct tumor cell intravasation, Proc. Natl. Acad. Sci.
- M. Glicksman, Z. Li and S. Markossian, et al., In Vitro Cell Based Assays, Assay Guidance Manual, 2023. 149
- M. S. Manak, J. S. Varsanik and B. J. Hogan, et al., Live-cell phenotypic-biomarker microfluidic assay for the risk stratification of cancer patients via machine learning, Nat. Biomed. Eng., 2018, 47(3), 549-562, DOI: 10.1038/s41551- 018-0285-z.Live-cell. 154 · doi:10.1038/s41551-018-0285-z.live-cell
- K. Sherkar, S. Choudante and O. Sumant, Organ-Tumor-on- a-Chip Market by Type (Lung Tumor-on-a-Chip, Bone Marrow Tumor-on-a-Chip, Brain Tumor-on-a-Chip, Breast Tumor-on-a- Chip, Urinary System Tumor-on-a-Chip, Intestine Tumor-on-a- Chip, and Liver Tumor-on-a-Chip): Global Opportunity Analysis and Industry Forecast, 2021-2030, 2021.
- D. Venturoli and B. Rippe, Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability, Am. J. Physiol. -Ren. Physiol., 2005, 288, 605-613, DOI: 10.1152/ajprenal.00171.2004.-Polydisperse. 225 · doi:10.1152/ajprenal.00171.2004.-polydisperse
Cited by
Engineering next generation vascularized organoids
Werschler, N., Quintard, C., Nguyen, S., & Penninger, J. M. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118529 · Cited by 69
Al-Kabani, A., Huda, B., Haddad, J., Yousuf, M., Bhurka, F., Ajaz, F., Patnaik, R., Jannati, S., & Banerjee, Y. (2025) · Cancers · doi:10.3390/cancers17132163 · Cited by 57
Assessing personalized responses to anti-PD-1 treatment using patient-derived lung tumor-on-chip
Veith, I., Nurmik, M., Mencattini, A., Damei, I., Lansche, C., Brosseau, S., Gropplero, G., Corgnac, S., Filippi, J., Poté, N., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101549 · Cited by 63
Self-citationCancer-on-a-chip for precision cancer medicine
Liu, L., Wang, H., Chen, R., Song, Y., Wei, W., Baek, D. S. H., Gillin, M., Kurabayashi, K., & Chen, W. (2025) · Lab on a Chip · doi:10.1039/d4lc01043d · Cited by 52
Sharma, P. K., & Chen, C. (2025) · Biosensors · doi:10.3390/bios15120793 · Cited by 35
Metadata
- Authors
- Bouquerel, C., Dubrova, A., Hofer, I., Phan, D. T. T., Bernheim, M., Ladaigue, S., Cavaniol, C., Maddalo, D., Cabel, L., Mechta-Grigoriou, F., Wilhelm, C., Zalcman, G., Parrini, M. C., & Descroix, S.
- Affiliations
- Inserm (FR)
- Institut Pierre-Gilles de Gennes pour la Microfluidique (FR)
- Pfizer (United States) (US)
- Macromolécules et Microsystèmes en Biologie et Médecine, UMR 168, Institut Curie, Institut Pierre Gilles de Gennes, 6 rue Jean Calvin, 75005, Paris, France
- Genentech (US)
- Institut Curie (FR)
- Stress and Cancer Laboratory, Inserm, U830, Institut Curie, PSL Research University, 26 rue d'Ulm, 75005, Paris, France
- Corresponding author
- Descroix, Stéphanie
- ORCID
- Venue
- Lab on a Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2023
- Volume
- 23
- Issue
- 18
- Pages
- 3906-3935
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- OpenAlex
- W4385969151
- Cited by
- 58
- References
- 222
- Citations by year
- 2026: 18 · 2025: 24 · 2024: 15 · 2023: 1
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Lab on a Chip (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- Funders
- Centre National de la Recherche Scientifique
- Association Nationale de la Recherche et de la Technologie
- Institut Pierre-Gilles de Gennes (ANR-10-IDEX-0001-02 PSL, ANR-10-EQPX-34, ANR-10-LABX-31)
- Fondation ARC pour la Recherche sur le Cancer (PGA12021010002992_3578)
- Institut National de la Santé et de la Recherche Médicale (19CR046-01, 53712INSERM/ITMO 20-DESCROIX 04/24)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Keywords
- tumor-on-a-chip, 3D tumor models, tumor microenvironment, patient-derived cells, tumor xenografts, clinical validation, preclinical drug testing, 3Rs, tumor progression, treatment response, extracellular matrix, mechanobiology, pharmaceutical industry
- MeSH terms
- Animals, Drug Industry, Extracellular Matrix, Humans, Neoplasms, Cell Culture Techniques, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.